Pfizer Inc. (NYSE: PFE): Acquisition of King Pharmaceuticals, Inc. (NYSE: KG)
H3GM served as special counsel to Pfizer Inc.(NYSE: PFE) on Tennessee legal issues in Pfizer's acquisition of King Pharmaceuticals, Inc. (NYSE: KG). Pfizer acquired King, a diversified specialty pharmaceutical discovery and clinical development company, for approximately $3.6 billion in cash. The acquisition was accomplished through a tender offer followed by a merger.
